Is It All Central Sensitization? Role of Peripheral Tissue Nociception in Chronic Musculoskeletal Pain

Abstract

Fibromyalgia syndrome (FM) is a highly prevalent musculoskeletal disorder that is often accompanied by somatic hyperalgesia (enhanced pain from noxious stimuli). Neural mechanisms of somatic hyperalgesia have been analyzed via quantitative sensory testing of FM patients. Results of these studies suggest that FM pain is associated with widespread primary and secondary cutaneous hyperalgesia, which are dynamically maintained by tonic impulse input from deep tissues and likely by brain-to-spinal cord facilitation. Enhanced somatic pains are accompanied by mechanical hyperalgesia and allodynia in FM patients as compared with healthy controls. FM pain is likely to be at least partially maintained by peripheral impulse input from deep tissues. This conclusion is supported by results of several studies showing that injection of local anesthetics into painful muscles normalizes somatic hyperalgesia in FM patients.

Evaluation of Pain Pressure Threshold and Widespread Pain in Chronic Low Back Pain

“…A number of studies have shown central sensitization to be responsible for sensory threshold changes and widespread tenderness, as well as peripheral sensitization (13,14,33). Tissue damage stimulates the release of numerous inflammatory mediators from neurons and immune cells (34), resulting in activation of nociceptors in the injury area and nociceptor hypersensitivity.…”

EEG Biofeedback Treatment Improves Certain Attention and Somatic Symptoms in Fibromyalgia: A Pilot Study

“…Nevertheless, a consensus exits that the era of viewing FMS as a purely ''psychological disorder'' is no longer tenable (Aaron et al 1996;Yunus et al 1991). Instead, FMS is now considered a (Lee et al 2011) and peripheral nervous sytem (PNS) abnormalities (Caro et al 2008;Staud 2010) whose manifestations may be colored by the affective state (Glesecke et al 2003). We reasoned, therefore, that its successful treatment might require a multisystem approach, and engender a role for EEG-BF therapy.…”

Potential Muscle Biomarkers of Chronic Myalgia in Humans - A Systematic Review of Microdialysis Studies

“…It is unknown whether a chronic pain condition can be driven by established central alterations such as central hyperexcitability, alterations in pain matrix, and alterations in descending mechanisms (facilitation) with very little or no peripheral stimuli or nociception. However, there are several indications that central alterations in nociceptive processing are driven by peripheral tissue alterations (Gerdle et al, 2008c) and peripheral nociceptive input (Schneider et al, 2010;Staud, 2010;Staud et al, 2009;Woolf, 2011).…”